Lerivon (Mianserin Hydrochloride)

Mianserin Hydrochloride works by blocking central α2‑adrenergic receptors, which increases the release of norepinephrine and serotonin. It also antagonises histamine H1 and serotonin 5‑HT2/5‑HT3 receptors, producing sedative and anxiolytic effects that help correct the neurotransmitter imbalances underlying depression.

The dosage of Lerivon is determined individually by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and tolerability. No fixed regimen is provided here; the prescriber will set the appropriate dose and titration schedule.

Safety data for Mianserin Hydrochloride in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Consequently, Lerivon should be used only if the potential benefit justifies the potential risk to the fetus or infant, and it is generally avoided unless absolutely necessary.

To order Lerivon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lerivon (Mianserin) belongs to the tetracyclic antidepressant class, differing from selective serotonin reuptake inhibitors (SSRIs) which primarily block serotonin reuptake. Mianserin’s broader receptor profile—blocking α2‑adrenergic, histamine, and serotonin receptors—often results in stronger sedative effects, which can be advantageous for patients with insomnia but may cause more anticholinergic side effects compared with SSRIs.

Lerivon tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children. Do not refrigerate or freeze the tablets.

Lerivon is taken orally as a tablet, usually with a glass of water. It can be taken with or without food, but consistent administration with respect to meals helps maintain stable plasma levels. Patients should follow the prescriber’s instructions regarding timing and any dose adjustments.

Serious risks include severe hypotension, cardiac arrhythmias, blood dyscrasias such as neutropenia or agranulocytosis, and the potential for seizures. Patients should seek immediate medical attention if they experience sudden drops in blood pressure, irregular heartbeats, unexplained infections, or convulsive episodes.

Lerivon is contraindicated in patients with known hypersensitivity to Mianserin or any excipients, those currently taking monoamine oxidase inhibitors, and individuals with uncontrolled severe cardiovascular disease. Caution is also advised for patients with hepatic impairment, a history of seizures, or significant electrolyte disturbances.